| Announce Date | 11/04/2025 |
| EPS Normalized Actual | $0.27 (Beat by $0.01) |
| EPS GAAP Actual | $0.27 (Beat by $0.01) |
| Revenue Actual | $0.155869B |
| Revenue Surprise | Beat by $155.869M |
| Announce Date | 03/29/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.24667 |
| EPS GAAP Estimate | $0.24667 |
| Revenue Estimate | $0.150278333B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 1.76 | 23.65 | 1.71847 | 1.81033 | 1 |
| Dec 2027 | 1.545 | 26.94 | 1.46 | 1.63 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.27 | -0.06667 | 0.155869B | 29.81% | 7.22M |
| FQ2 2025 (Jun 2025) | 0.3 | 0.3 | 0.157109B | 8.15% | 157.11M |
| FQ1 2025 (Mar 2025) | 0.23 | 0.23 | 0.130106B | -5.96% | 130.11M |
| FQ4 2024 (Dec 2024) | 0.8 | 0.8 | 0.175984B | 29.21% | 175.98M |
| FQ3 2024 (Sep 2024) | 0.09 | 0.09 | 0.109408B | -14.36% | 109.41M |
| FQ2 2024 (Jun 2024) | 0.31 | 0.31 | 0.144309B | 16.09% | 144.31M |
| FQ1 2024 (Mar 2024) | 0.18 | 0.18 | 0.13786B | 18.94% | 137.86M |
| FQ4 2023 (Dec 2023) | 0.25 | 0.25 | 0.124583B | 0.75% | 124.58M |
FQ4 Announce Date
03/29/2026 (Pre-Market)
Consensus EPS Estimates
0.24667
Consensus Revenue Estimates
0.150278333B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Oct 2026) | 0.39 | -- | 0.37983 | 0.39446 | 3 |
| FQ3 2026 (Jul 2026) | 0.36 | 25 | 0.35061 | 0.36412 | 3 |
| FQ2 2026 (Jun 2026) | 0.35 | 14.29 | 0.33508 | 0.36039 | 1 |
| FQ1 2026 (Mar 2026) | 0.24667 | 6.76 | 0.23615 | 0.254 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Oct 2026) | 0.16B | -- | 0.16B | 0.16B | 4 |
| FQ3 2026 (Jul 2026) | 0.15B | -1.14 | 0.15B | 0.16B | 4 |
| FQ2 2026 (Jun 2026) | 0.17B | 5.21 | 0.16B | 0.17B | 1 |
| FQ1 2026 (Mar 2026) | 0.15B | 13.42 | 0.15B | 0.15B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.33667 | 0.27 | -0.06667 | -24.69% |
| FQ2 2025 (Jun 2025) | 0.3 | 0.3 | 100% | |
| FQ1 2025 (Mar 2025) | 0.23 | 0.23 | 100% | |
| FQ4 2024 (Dec 2024) | 0.8 | 0.8 | 100% | |
| FQ3 2024 (Sep 2024) | 0.09 | 0.09 | 100% | |
| FQ2 2024 (Jun 2024) | 0.31 | 0.31 | 100% | |
| FQ1 2024 (Mar 2024) | 0.18 | 0.18 | 100% | |
| FQ4 2023 (Dec 2023) | 0.25 | 0.25 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.15B | $0.16B | $7.22M | 4.63% |
| FQ2 2025 (Jun 2025) | $0B | $0.16B | $157.11M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.13B | $130.11M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.18B | $175.98M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.11B | $109.41M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.14B | $144.31M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.14B | $137.86M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.12B | $124.58M | 100% |